Full video transcriptClick to expand
Auto-generated transcript of @yesitsmeveronica's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I have had a ton of questions about GHQ and hair growth.
- 0:05Look guys, I wanted to show you all the new hair.
- 0:09This is all since I started the GHQ.
- 0:13Look at this, this is all new.
- 0:15There's so much.
- 0:16It's all throughout my scalp.
- 0:17If I start looking, it's everywhere.
- 0:20And just all of this area was bald.
- 0:23I had lost it during COVID and then I had lost more
- 0:26when I originally had lost weight.
- 0:28Look, it's all coming back.
- 0:30Gray hairs and all sister.
- 0:32Which by the way, I am seeing less gray hairs,
- 0:34which is kind of crazy.
- 0:35But I knew that the NAD plus would help with that
- 0:38and the GHQC it would look.
- 0:40It works.
Peptide therapy TikTok claims: separating hype from human data
Quick answer
The creator appears to be using GHK-Cu (a copper tripeptide with documented follicle-stimulating activity in preclinical research) alongside NAD+ precursors following hair loss attributed to COVID-related telogen effluvium and caloric restriction. Telogen effluvium is self-limiting in most cases, which makes attributing observed regrowth to any specific intervention methodologically unreliable without a control condition. The gray hair reversal claim carries no meaningful clinical support from human trials as of current published literature.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Peptide therapy TikTok claims: separating hype from human data, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Peptide therapy TikTok claims: separating hype from human data is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Peptide therapy TikTok claims: separating hype from human data" from Veronica Cardenas. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator appears to be using GHK-Cu (a copper tripeptide with documented follicle-stimulating activity in preclinical research) alongside NAD+ precursors following hair loss attributed to COVID-related telogen effluvium and caloric restriction.
The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7501362306555661599." In this clip, the useful excerpt is: "I have had a ton of questions about GHQ and hair growth." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator appears to be using GHK-Cu (a copper tripeptide with documented follicle-stimulating activity in preclinical research) alongside NAD+ precursors following hair loss attributed to COVID-related telogen effluvium and caloric restriction.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator appears to be using GHK-Cu (a copper tripeptide with documented follicle-stimulating activity in preclinical research) alongside NAD+ precursors following hair loss attributed to COVID-related telogen effluvium and caloric restriction. Telogen effluvium is self-limiting in most cases, which makes attributing observed regrowth to any specific intervention methodologically unreliable without a control condition. The gray hair reversal claim carries no meaningful clinical support from human trials as of current published literature.
- GHK-Cu has demonstrated follicle-stimulating effects in preclinical models, but randomized controlled human trial data for hair regrowth is limited as of 2024.
- COVID-related telogen effluvium resolves on its own in the majority of patients within 3-6 months, making any concurrent intervention difficult to credit for recovery (Mieczkowska et al., 2021, JEADV).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- GHK-Cu has demonstrated follicle-stimulating effects in preclinical models, but randomized controlled human trial data for hair regrowth is limited as of 2024.
- COVID-related telogen effluvium resolves on its own in the majority of patients within 3-6 months, making any concurrent intervention difficult to credit for recovery (Mieczkowska et al., 2021, JEADV).
- No published clinical trial supports the claim that NAD+ supplementation reverses hair graying in humans.
- GHK-Cu's antioxidant properties are documented in vitro, but in vitro effects do not reliably translate to clinical outcomes like melanin restoration.
- Weight-loss-related hair shedding, like stress-induced telogen effluvium, typically resolves after caloric and nutritional stabilization regardless of peptide use.
- The creator appears to conflate two distinct compounds with different proposed mechanisms, which should prompt caution about her interpretation of results.
- Anyone concerned about patterned hair loss should consult a dermatologist, as androgenetic alopecia has a different biology and treatment response profile than telogen effluvium.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @yesitsmeveronica actually say?
The creator says she lost significant hair during COVID and after weight loss, started something she calls "GHQ" (almost certainly GHK-Cu, a copper peptide), and is now seeing visible regrowth all over her scalp. She also says she's noticing fewer gray hairs, which she attributes to both NAD+ and GHK-Cu. Her words: "I am seeing less gray hairs, which is kind of crazy." She frames this as confirmation that the combination works, based entirely on her own visual observation.
To be clear about the substance: GHK-Cu is a naturally occurring copper-binding peptide. It's not a fringe compound. It appears in human plasma and has been studied for wound healing and skin biology. NAD+ precursors are a separate category entirely and she appears to be conflating two distinct mechanisms. The confidence here outpaces the evidence significantly.
Does the science back this up?
Partially, and with a lot of caveats. GHK-Cu does have real preclinical data supporting hair follicle activity, but the human trial evidence is thin and the gray hair reversal claim has almost no solid clinical backing.
A 2019 paper by Pickart and Margolina in Cosmetics summarized GHK-Cu's effects on hair follicles, noting it can stimulate follicle size and hair shaft diameter in tissue models. Separate work by Rushton (2002, Clinical and Experimental Dermatology) identified nutritional deficiencies, including those related to copper metabolism, as contributors to hair loss. So the biological plausibility exists for follicle-related effects.
On gray hair reversal: melanocyte function is complex. NAD+ precursors like NMN and NR have been studied for cellular energy metabolism, but no peer-reviewed clinical trial has demonstrated that NAD+ supplementation reverses graying in humans. A 2021 study by Covarrubias et al. in Nature Metabolism showed NAD+ metabolism influences cellular aging broadly, but graying specifically is not a validated endpoint. The claim here is a stretch.
What did they get wrong (or right)?
She got the hair regrowth plausibility partially right. COVID-related hair loss is typically telogen effluvium, a temporary shedding triggered by systemic stress. Telogen effluvium often resolves on its own within three to six months of the triggering event, regardless of intervention. Weight-loss-related shedding follows a similar pattern. Without a control condition, there is no way to know whether her regrowth is from GHK-Cu, natural recovery, improved nutrition, or time.
She got the gray hair claim wrong. Saying "I am seeing less gray hairs" and immediately crediting NAD+ and GHK-Cu is a post hoc attribution with no mechanism established in humans. Melanin production depends on melanocyte stem cell activity, oxidative stress, and follicle cycling. GHK-Cu has antioxidant properties in vitro, but that does not equal clinical gray reversal. This is the part of the video that crosses from anecdote into misinformation territory.
- COVID and weight-loss-related hair loss frequently resolves without treatment
- GHK-Cu has follicle-stimulating signals in preclinical models
- Gray hair reversal via peptides or NAD+ is not supported by clinical trials
- Her product names are unclear and she may be combining compounds without understanding their separate mechanisms
What should you actually know?
If you are considering GHK-Cu for hair loss, here is what the evidence actually supports: it has biological activity at follicle receptors, it has a reasonable safety profile in topical use, and there is early-stage human data suggesting possible benefit. That is meaningfully different from "it reversed my baldness."
For NAD+ and gray hair specifically: this claim should be treated with skepticism until a randomized controlled trial says otherwise. Correlation between starting a supplement regimen and noticing cosmetic changes is not causation. Hair also grows and changes in cycles that are influenced by stress reduction, diet changes, and dozens of other variables that shift when someone commits to a health routine.
Anyone seeing this video and interpreting it as clinical evidence is being done a disservice. The creator's experience may be real, but the explanation she offers is speculative. If hair regrowth matters to you medically, a dermatologist can assess whether your loss pattern is the kind that responds to follicle-targeted treatments, and which treatments have actual trial data behind them.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Veronica Cardenas · TikTok creator
157.5K views on this video
Peptide therapy TikTok claims: separating hype from human data
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about ghk-cu has demonstrated follicle-stimulating effects in preclinical models,?
GHK-Cu has demonstrated follicle-stimulating effects in preclinical models, but randomized controlled human trial data for hair regrowth is limited as of 2024.
What does the video say about covid-related telogen effluvium resolves on its own in the majority?
COVID-related telogen effluvium resolves on its own in the majority of patients within 3-6 months, making any concurrent intervention difficult to credit for recovery (Mieczkowska et al., 2021, JEADV).
What does the video say about no published clinical trial supports the claim?
No published clinical trial supports the claim that NAD+ supplementation reverses hair graying in humans.
What does the video say about ghk-cu's antioxidant properties?
GHK-Cu's antioxidant properties are documented in vitro, but in vitro effects do not reliably translate to clinical outcomes like melanin restoration.
What does the video say about weight-loss-related hair shedding, like stress-induced telogen effluvium, typically resolves after?
Weight-loss-related hair shedding, like stress-induced telogen effluvium, typically resolves after caloric and nutritional stabilization regardless of peptide use.
What does the video say about the creator appears to conflate two distinct compounds with different?
The creator appears to conflate two distinct compounds with different proposed mechanisms, which should prompt caution about her interpretation of results.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Veronica Cardenas, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.